Pay in 4 interest-free payments of $7.16 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
R.StrazzariM
Each item ships as its own lyophilized, research-grade vial at 99% HPLC purity, with a Certificate of Analysis available on request.
Rational identification of a Cdc42 inhibitor presents a new regimen for long-term hematopoietic stem cell mobilization
Different populations
Large-scale studies and regulatory reviews have found no increased breast cancer risk among patients using GLP-1 medicines
First, the researchers grew pigment-producing cells (melanocytes) in a flask in a laboratory and treated them with the SIKi drug or a control substance
US$ 23.93
US$ 25.51
US$ 20.27
US$ 20.42
US$ 27.64
